Advertisement

Topics

European regulators greenlight U.S. biotech's kidney cancer drug

03:52 EDT 23 Jun 2017 | Reuters

(Reuters) - European regulators on Friday recommended approving Aveo Pharmaceuticals Inc's drug to treat kidney cancer, marking a victory for the U.S. biotech that has faced setbacks in bringing the drug to market.

Original Article: European regulators greenlight U.S. biotech's kidney cancer drug

NEXT ARTICLE

More From BioPortfolio on "European regulators greenlight U.S. biotech's kidney cancer drug"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...